Anti-Fibrillin 1 antibody [11C1.3] (Biotin) (ab24826)

Overview

  • Product name
    Anti-Fibrillin 1 antibody [11C1.3] (Biotin)
    See all Fibrillin 1 primary antibodies
  • Description
    Mouse monoclonal [11C1.3] to Fibrillin 1 (Biotin)
  • Conjugation
    Biotin
  • Specificity
    This antibody recognises fibrillin (Mr 350 kDa).
  • Tested applications
    Suitable for: IHC-Fr, IHC-P, ICC/IF, Electron Microscopy, WBmore details
  • Species reactivity
    Reacts with: Cow, Human
  • Immunogen

    Microfibrils from zonular apparatus of bovine eye.

Properties

  • Form
    Liquid
  • Storage instructions
    Shipped at 4°C. Store at +4°C short term (1-2 weeks). Store at -20°C or -80°C. Avoid freeze / thaw cycle.
  • Storage buffer
    Preservative: 0.1% Sodium Azide
    Constituents: PBS
  • Concentration information loading...
  • Purity
    IgG fraction
  • Clonality
    Monoclonal
  • Clone number
    11C1.3
  • Isotype
    IgG1
  • Light chain type
    kappa
  • Research areas

Applications

Our Abpromise guarantee covers the use of ab24826 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
IHC-Fr
IHC-P
ICC/IF
Electron Microscopy
WB
  • Application notes
    Electron Microscopy: Use at an assay dependent dilution.
    IF: Use at an assay dependent dilution.
    IHC-P: 1/200. Perform heat mediated antigen retrieval via the microwave/citrate buffer method before commencing with IHC staining protocol.
    IHC-Fr: 1/200 - 1/500.
    WB: Use at a concentration of 1 µg/ml. Predicted molecular weight: 312 kDa.


    Not yet tested in other applications.
    Optimal dilutions/concentrations should be determined by the end user.
  • Target

    • Function
      Fibrillins are structural components of 10-12 nm extracellular calcium-binding microfibrils, which occur either in association with elastin or in elastin-free bundles. Fibrillin-1-containing microfibrils provide long-term force bearing structural support. Regulates osteoblast maturation by controlling TGF-beta bioavailability and calibrating TGF-beta and BMP levels, respectively.
    • Involvement in disease
      Defects in FBN1 are a cause of Marfan syndrome (MFS) [MIM:154700]. MFS is an autosomal dominant disorder that affects the skeletal, ocular, and cardiovascular systems. A wide variety of skeletal abnormalities occurs with MFS, including scoliosis, chest wall deformity, tall stature, abnormal joint mobility. Ectopia lentis occurs in up to about 80% of MFS patients and is almost always bilateral. The leading cause of premature death in MFS patients is progressive dilation of the aortic root and ascending aorta, causing aortic incompetence and dissection. Note=The majority of the more than 600 mutations in FBN1 currently known are point mutations, the rest are frameshifts and splice site mutations. Marfan syndrome has been suggested in at least 2 historical figures, Abraham Lincoln and Paganini.
      Defects in FBN1 are a cause of isolated ectopia lentis (EL) [MIM:129600]. The symptoms of this autosomal dominant fibrillinopathy overlap with those of Marfan syndrome, with the exclusion of the skeletal and cardiovascular manifestations.
      Defects in FBN1 are the cause of Weill-Marchesani syndrome autosomal dominant (ADWMS) [MIM:608328]. A rare connective tissue disorder characterized by short stature, brachydactyly, joint stiffness, and eye abnormalities including microspherophakia, ectopia lentis, severe myopia and glaucoma.
      Defects in FBN1 are a cause of Shprintzen-Goldberg craniosynostosis syndrome (SGS) [MIM:182212]. SGS is a very rare syndrome characterized by a marfanoid habitus, craniosynostosis, characteristic dysmorphic facial features, skeletal and cardiovascular abnormalities, mental retardation, developmental delay and learning disabilities.
      Defects in FBN1 are a cause of overlap connective tissue disease (OCTD) [MIM:604308]. A heritable disorder of connective tissue characterized by involvement of the mitral valve, aorta, skeleton, and skin. MASS syndrome is closely resembling both the Marfan syndrome and the Barlow syndrome. However, no dislocation of the lenses or aneurysmal changes occur in the aorta, and the mitral valve prolapse is by no means invariable.
      Defects in FBN1 are a cause of stiff skin syndrome (SSKS) [MIM:184900]. It is a syndrome characterized by hard, thick skin, usually over the entire body, which limits joint mobility and causes flexion contractures. Other occasional findings include lipodystrophy and muscle weakness.
    • Sequence similarities
      Belongs to the fibrillin family.
      Contains 47 EGF-like domains.
      Contains 9 TB (TGF-beta binding) domains.
    • Post-translational
      modifications
      Forms intermolecular disulfide bonds either with other fibrillin-1 molecules or with other components of the microfibrils.
    • Cellular localization
      Secreted > extracellular space > extracellular matrix.
    • Information by UniProt
    • Database links
    • Alternative names
      • 350 kDa glycoprotein component extracellular microfibril antibody
      • ACMICD antibody
      • FBN 1 antibody
      • FBN antibody
      • FBN1 antibody
      • FBN1_HUMAN antibody
      • Fibrillin 15 antibody
      • Fibrillin-1 antibody
      • Fibrillin1 antibody
      • Fibrillin15 antibody
      • GPHYSD2 antibody
      • Marfan syndrome antibody
      • MASS antibody
      • MFS 1 antibody
      • MFS1 antibody
      • OCTD antibody
      • SGS antibody
      • SSKS antibody
      • Weill Marchesani syndrome antibody
      • WMS antibody
      • WMS2 antibody
      see all

    References for Anti-Fibrillin 1 antibody [11C1.3] (Biotin) (ab24826)

    This product has been referenced in:
    • Maier A  et al. Fibrillin and elastin networks in extrafusal tissue and muscle spindles of bovine extraocular muscles. Invest Ophthalmol Vis Sci 35:3103-10 (1994). Read more (PubMed: 8206729) »
    • Wright DW  et al. Immunization with undenatured bovine zonular fibrils results in monoclonal antibodies to fibrillin. Matrix Biol 14:41-9 (1994). Read more (PubMed: 8061919) »

    See all 2 Publications for this product

    Product Wall

    Abcam has not validated the combination of species/application used in this Abreview.
    Application
    Flow Cytometry
    Sample
    Human Cell (Human dermal fibroblasts)
    Permeabilization
    Yes - BD Perm/Wash buffer 1X
    Gating Strategy
    Live cells
    Specification
    Human dermal fibroblasts
    Preparation
    Cell harvesting/tissue preparation method: Trypsin
    Sample buffer: BD Perm/Wash buffer 1X
    Fixation
    BD Cytofix/Cytoperm solution
    Username

    Abcam user community

    Verified customer

    Submitted Jan 06 2017

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

    Sign up